SHR-7787

SHR-7787 · Shanghai Hengrui Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SHR-7787, covering 2024-10-18 to 2026-01-12. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of SHR-7787 Injection Combined With Other Anti-tumor Drugs in Patients With Malignant Solid Tumors [Phase 2]

See pricing